Serinus Biosciences logo

Serinus Biosciences

Powering drug development with cellular precision

7 employees · est. 2022

VS
Sola Diagnostics GmbH logo

Sola Diagnostics GmbH

The WID®-easy Test - Now also available in Switzerland 🇨🇭 👉 Unnecessary hysteroscopy and curettage can be avoided

2 employees · est. 2020 · Innsbruck, Austria

Sola Diagnostics GmbH is the older company (2022 vs 2020).

Side-by-Side Comparison

Serinus Biosciences Sola Diagnostics GmbH
Founded
2022 2020 older
Headquarters
Not tracked yet Innsbruck, Austria
Employees
7 2
Industry
Biotechnology Biotechnology, Health Care
Funding Stage
Pre Seed Seed
Total Funding
$500.00K $2.39M
Funding Rounds
1 5
Services
Not tracked yet Developing and providing epigenetic diagnostic tests for gynecological cancer detection
Target Customers
Not tracked yet Patients, healthcare providers, and laboratories
Taxonomy
Precision Medicine, Cancer Biology, AI/ML, Computational Biology, Drug Development, Cellular Precision, Therapeutics, Functional Genomics, Molecular Landscape, Resistance Mechanisms, Knowledge-primed AI Engine, New York City, Startup, Innovation Women's Health Diagnostics, Epigenetic Testing, Gynecological Diagnostics, DNA Methylation, PCR-based Analysis, Clinical Validation, First-line Diagnostic, Non-invasive Testing, Cancer Detection, Startup Expansion, Private Equity Investment
Website
serinus.bio sola-diagnostics.com
Serinus Biosciences logo

About Serinus Biosciences

Serinus Biosciences is a biotechnology startup founded in 2022 with the slogan "Powering drug development with cellular precision." The company is focused on redefining precision in cancer therapeutics by designing models to determine how molecules function inside each tumor cell. Through their know...

Sola Diagnostics GmbH logo

About Sola Diagnostics GmbH

Sola Diagnostics GmbH is a biotechnology and healthcare startup which is the home of the WID®-Test. Founded in 2020 and headquartered in Austria, the company has recently secured a €400.00K Seed Round investment from FPS-Holding on 20 February 2025. Their slogan "The WID®-easy Test - Now also availa...

We will tell you when either one moves

BounceWatch watches Serinus Biosciences and Sola Diagnostics GmbH for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Serinus Biosciences and Sola Diagnostics GmbH — by email.

Frequently Asked Questions

Serinus Biosciences — Powering drug development with cellular precision. Sola Diagnostics GmbH — The WID®-easy Test - Now also available in Switzerland 🇨🇭 👉 Unnecessary hysteroscopy and curettage can be avoided. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Serinus Biosciences has raised $500.00K while Sola Diagnostics GmbH has raised $2.39M.
Serinus Biosciences and Sola Diagnostics GmbH operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Serinus Biosciences with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Serinus Biosciences on 13 Sep 2024, and Sola Diagnostics GmbH on 13 Apr 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy